[go: up one dir, main page]

EA200000977A1 - COMPOSITIONS PAROXETINE - Google Patents

COMPOSITIONS PAROXETINE

Info

Publication number
EA200000977A1
EA200000977A1 EA200000977A EA200000977A EA200000977A1 EA 200000977 A1 EA200000977 A1 EA 200000977A1 EA 200000977 A EA200000977 A EA 200000977A EA 200000977 A EA200000977 A EA 200000977A EA 200000977 A1 EA200000977 A1 EA 200000977A1
Authority
EA
Eurasian Patent Office
Prior art keywords
paroxetine
compositions
depression
therapy
carrier
Prior art date
Application number
EA200000977A
Other languages
Russian (ru)
Other versions
EA003393B1 (en
Inventor
Эндрю Симон Крэйг
Нил Уорд
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA200000977A1 publication Critical patent/EA200000977A1/en
Publication of EA003393B1 publication Critical patent/EA003393B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к пароксетину, адсорбированному на носителе с получением свободнотекучего порошка, используемого для заполнения капсул или получения таблеток; и применению его в терапии для лечения депрессии.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention relates to paroxetine adsorbed onto a carrier to produce a free flowing powder used for filling capsules or for preparing tablets; and its use in therapy for the treatment of depression. The international application was published along with an international search report.

EA200000977A 1998-03-24 1999-03-24 Paroxetine compositions EA003393B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations
PCT/GB1999/000922 WO1999048499A1 (en) 1998-03-24 1999-03-24 Paroxetine compositions

Publications (2)

Publication Number Publication Date
EA200000977A1 true EA200000977A1 (en) 2001-02-26
EA003393B1 EA003393B1 (en) 2003-04-24

Family

ID=10829181

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000977A EA003393B1 (en) 1998-03-24 1999-03-24 Paroxetine compositions

Country Status (20)

Country Link
EP (1) EP1063993A1 (en)
JP (1) JP2002507569A (en)
CN (1) CN1125639C (en)
AP (1) AP2000001914A0 (en)
AU (1) AU754765B2 (en)
BG (1) BG104865A (en)
BR (1) BR9908991A (en)
CA (1) CA2324612A1 (en)
EA (1) EA003393B1 (en)
GB (1) GB9806312D0 (en)
HU (1) HUP0101326A3 (en)
ID (1) ID26485A (en)
IL (1) IL138478A0 (en)
NO (1) NO313404B1 (en)
NZ (1) NZ506893A (en)
PL (1) PL343095A1 (en)
SK (1) SK14102000A3 (en)
TR (1) TR200002750T2 (en)
WO (1) WO1999048499A1 (en)
ZA (1) ZA200005697B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK200100341A (en) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Process for the preparation of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
JP5134818B2 (en) * 2003-07-02 2013-01-30 アボット・ラボラトリーズ Method for the manufacture of lipid controlled drug formulations
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) * 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
CN103961333B (en) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 Paroxetine mesylate capsule and preparation method thereof
CN104027306A (en) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 Paroxetine oral suspension and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (en) * 1985-10-25 1994-11-01 Beecham Group Plc DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT.
SK283608B6 (en) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Anhydrous paroxetine hydrochloride, process for its preparation and use
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
BR9908991A (en) 2000-12-12
ID26485A (en) 2001-01-11
AU754765B2 (en) 2002-11-21
JP2002507569A (en) 2002-03-12
NO20004740D0 (en) 2000-09-22
GB9806312D0 (en) 1998-05-20
EP1063993A1 (en) 2001-01-03
SK14102000A3 (en) 2001-03-12
CN1125639C (en) 2003-10-29
ZA200005697B (en) 2001-10-02
HUP0101326A2 (en) 2002-05-29
BG104865A (en) 2001-05-31
HUP0101326A3 (en) 2002-06-28
NO313404B1 (en) 2002-09-30
EA003393B1 (en) 2003-04-24
CA2324612A1 (en) 1999-09-30
NO20004740L (en) 2000-10-03
AP2000001914A0 (en) 2000-09-30
NZ506893A (en) 2003-06-30
IL138478A0 (en) 2001-10-31
PL343095A1 (en) 2001-07-30
AU3045199A (en) 1999-10-18
WO1999048499A1 (en) 1999-09-30
TR200002750T2 (en) 2000-12-21
CN1294512A (en) 2001-05-09

Similar Documents

Publication Publication Date Title
SE9704545D0 (en) Novel compounds
SE9704544D0 (en) Novel compounds
SE9704546D0 (en) Novel compounds
DE69940769D1 (en) ORAL LIQUID COMPOSITIONS
SE9904505D0 (en) Novel compounds
BR0215281A (en) Fused heterocyclic succinimide compounds and their analogues, modulators of nuclear hormone receptor function
HUP0100950A3 (en) Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
PT1319007E (en) FUSED HETEROCYCLIC SUCCINIMIDE COMPOUNDS AND ITS ANALOGS AS FUNCTION MODULATORS OF NUCLEAR HORMONAL RECEPTORS
MY136520A (en) Novel compounds
EE02962B1 (en) Mometasone furoate monohydrate, process for its preparation and pharmaceutical compositions
ATE420880T1 (en) CONDENSED CYCLIC MODULATORS OF THE FUNCTION OF NUCLEAR HORMONE RECEPTORS
ATE433756T1 (en) JELLILED COMPOSITIONS
SE9901875D0 (en) Novel compounds
AU2002364082A8 (en) Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
EA200301275A1 (en) CAPSULES FOR INHALATION
DK1578406T3 (en) Modified Release Pharmaceutical Composition
EA200500388A1 (en) METHOD OF OBTAINING DRY POWDER COMPOSITIONS FOR INHALATION
DE69034226D1 (en) Preparation process of huperzine A and its analogs and compounds useful thereto
YU13301A (en) Muscarinic agonists and antagonists
YU59400A (en) Azabicyclic 5ht1 receptor ligands
EA200000977A1 (en) COMPOSITIONS PAROXETINE
ATE280588T1 (en) DEXTRAN-LEPTIN CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS
EA200300727A1 (en) DERIVATIVES OF 2H-1-BENZOPIRANE, METHODS OF THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS
EA200100098A1 (en) SALT PAROXETINE
MXPA03004111A (en) Compositions of n- (methylethylaminocarbonyl) -4-(3 -methylphenylamino)-3- pyridylsulfonamide and cyclic oligosaccharides.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU